Inhibition of intrinsic protein tyrosine kinase activity of EGF-receptor kinase complex from human breast cancer cells by the marine sponge metabolite (+)-aeroplysinin-1.

1. (+)-Aeroplysinin-1, a naturally occurring tyrosine metabolite from the marine sponge Verongia aerophoba, was found to inhibit the phosphorylation of lipocortin-like proteins by a highly purified preparation of the epidermal growth factor (EGF) receptor-tyrosine protein kinase complex from MCF-7 breast carcinoma cells. 2. (+)-Aeroplysinin-1 blocked the EGF-dependent proliferation of both MCF-7 and ZR-75-1 human breast cancer cells and inhibited the ligand-induced endocytosis of the EGF receptor in vitro. 3. Treatment with aeroplysinin-1 in the concentration range at 0.25-0.5 microM resulted in a time- and dose-dependent total tumor cell death in vitro. 4. At a 10-fold higher concentration the compound did not reveal any cytostatic activity in normal human fibroblasts. 5. From these data we conclude that (+)-aeroplysinin-1 represents a compound which displays a strong anti-tumor effect on EGF-dependent tumor cell lines.

[1]  J. Glenney.  Two related but distinct forms of the Mr 36,000 tyrosine kinase substrate (calpactin) that interact with phospholipid and actin in a Ca2+-dependent manner. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[2]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[3]  S. Cohen,et al.  Epidermal growth factor stimulates the phosphorylation of the calcium-dependent 35,000-dalton substrate in intact A-431 cells. , 1985, The Journal of biological chemistry.

[4]  G. Carpenter,et al.  Epidermal growth factor-receptor-protein kinase interactions. , 1981, Progress in clinical and biological research.

[5]  B. Diehl-seifert,et al.  Biphasic and differential effects of the cytostatic agents avarone and avarol on DNA metabolism of human and murine T and B lymphocytes. , 1986, European journal of cancer & clinical oncology.

[6]  E. Fattorusso,et al.  Aeroplysinin-I, a new bromo-compound from Aplysina aerophoba , 1970 .

[7]  G. Stoll,et al.  Antibodies to calcium/phospholipid binding protein (calelectrin) recognize neurons, astrocytes and schwann cells in the nervous system of rat , 1988, Neuroscience Letters.

[8]  Y. Kuchino,et al.  Suppression of the modulatory effects of the antileukemic and anti-human immunodeficiency virus compound avarol on gene expression by tryptophan. , 1989, Cancer research.

[9]  R. Tsien,et al.  Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor , 1987, Nature.

[10]  T. Steck,et al.  Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes. , 1974, Methods in enzymology.

[11]  R. Pepinsky,et al.  Epidermal growth factor-dependent phosphorylation of lipocortin , 1986, Nature.

[12]  B. Hamilton,et al.  Receptor binding and processing of epidermal growth factor by human breast cancer cells. , 1982, The Journal of clinical endocrinology and metabolism.

[13]  M. Bachmann,et al.  Potentiation of the cytostatic effect of bleomycin on L5178y mouse lymphoma cells by pepleomycin. , 1983, European journal of cancer & clinical oncology.

[14]  E. Racker,et al.  Synthetic tyrosine polymers as substrates and inhibitors of tyrosine-specific protein kinases. , 1984, The Journal of biological chemistry.

[15]  Michael Chinkers,et al.  A native 170,000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles. , 1982, The Journal of biological chemistry.

[16]  A. Ullrich,et al.  Growth factor receptor tyrosine kinases. , 1988, Annual review of biochemistry.

[17]  J. Brugge.  The p35 p36 substrates of protein-tyrosine kinases as inhibitors of phospholipase A2 , 1986, Cell.

[18]  W. Müller,et al.  Cytostatic Activity of Aeroplysinin-1 against Lymphoma and Epithelioma Cells , 1989, Zeitschrift fur Naturforschung. C, Journal of biosciences.

[19]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[20]  V. P. Whittaker,et al.  The separation and characterization of two forms of Torpedo electric organ calelectrin. , 1988, Biochimica et biophysica acta.

[21]  L. Engel,et al.  Human breast carcinoma cells in continuous culture: a review. , 1978, Cancer research.

[22]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[23]  G. Carpenter,et al.  Receptors for epidermal growth factor and other polypeptide mitogens. , 1987, Annual review of biochemistry.

[24]  S. Cohen,et al.  Isolation of a calcium-dependent 35-kilodalton substrate for the epidermal growth factor receptor/kinase from A-431 cells. , 1984, The Journal of biological chemistry.

[25]  S. O’Brien,et al.  Establishment and characterization of three new continuous cell lines derived from human breast carcinomas. , 1978, Cancer research.

[26]  M. Crumpton,et al.  Primary structure of the human, membrane‐associated Ca2+‐binding protein p68 a novel member of a protein family. , 1988, The EMBO journal.

[27]  D Rodbard,et al.  Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.

[28]  P. B. Moore.  Calcimedin, calelectrin: correlation of relatedness. , 1988, Biochemical and biophysical research communications.

[29]  G. M. Walton,et al.  Ligand-induced endocytosis of the EGF receptor is blocked by mutational inactivation and by microinjection of anti-phosphotyrosine antibodies , 1988, Cell.

[30]  C. Jenkin,et al.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. , 1978, Immunochemistry.

[31]  G. Gibson,et al.  Characterization of epidermal growth factor receptor in primary human non-small cell lung cancer. , 1989, Cancer research.

[32]  K. Friese,et al.  Differential effect of insulin and epidermal growth factor on the mRNA translocation system and transport of specific poly(A+) mRNA and poly(A-) mRNA in isolated nuclei. , 1990, Biochemistry.

[33]  Jonathan A. Cooper,et al.  C-kinase phosphorylates the epidermal growth factor receptor and reduces its epidermal growth factor-stimulated tyrosine protein kinase activity. , 1984, The Journal of biological chemistry.

[34]  M. Bozzola,et al.  Neonatal serum growth-promoting activity measured in human lymphocytes: comparison of cord and capillary blood. , 1985, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[35]  J. Glenney,et al.  Amino-terminal sequence of p36 and associated p10: identification of the site of tyrosine phosphorylation and homology with S-100. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[36]  R. D. Mills,et al.  [Isolation and absolute configuration of the aeroplysinin I enantiomorphic pair from ianthella ardis]. , 1970, Tetrahedron letters.

[37]  T. Hunter,et al.  Transforming gene product of Rous sarcoma virus phosphorylates tyrosine , 1980, Proceedings of the National Academy of Sciences.

[38]  K. Friese,et al.  Role of phospholipase A2 in the stimulation of sponge cell proliferation by homologous lectin , 1989, Cell.